
Signadori Bio
Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
About
Signadori Bio SAS is a preclinical-stage biopharmaceutical company focused on developing an innovative immunotherapy platform. Their approach utilizes in vivo engineered monocytes, designed to be an off-the-shelf solution for treating solid tumors. The company aims to advance novel therapeutic strategies in oncology.
Show 6 more similar companies
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Shares Biotechnology, Drug Discovery
Biotechnology company developing and commercializing cell therapies for cancer treatment.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Drug Discovery
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Pharmaceuticals
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Signadori Bio?
People comparing tools land here. Get listed beside these.
Copy Signadori Bio's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- signadoribio.com
- Headquarters
- Paris, France
- Founded
- 2025
- Founders
- Jean-Luc Perfettini, Nathalie Chaput
- Total funding
- $12.2M (Seed Extension)
- Business model
- B2B
Funding rounds
- $11.1M6 May 2026Seed ExtensionLargest round
- $1.1M7 Apr 2025
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 6 May 2026 | Seed Extension | $11.1M | |
| 7 Apr 2025 | Seed | $1.1M |
Tech stack
Detected on signadoribio.com, last scanned 17 Nov 2026. Run your own scan
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Benchmarking
See how your site ranks against 16,849 startups
Signadori Bio sits in the 17th percentile for Domain Rating. Check where yours lands, free.
Signadori Bio has a Domain Rating of 10, the 17th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Bottom 25%
Check yoursAgent Readiness
Below median
Scan yoursSite Speed
Above median
PageSpeedData Trust
Above median
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Signadori Bio scores 40. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Signadori Bio changes
Used Signadori Bio? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Is Signadori Bio growing?
Yes, fast. Our data shows it raised $11M in a Seed Extension in May 2026, more than the $1.1M it raised in all the years before.
Who owns Signadori Bio?
Signadori Bio is privately held, owned by its founders and investors. Sofinnova Partners has backed 2 of the 2 rounds on record since April 2025, ahead of Invivo Capital (2), so it is likely among the largest outside shareholders. Exact stakes are not public.
Are there companies like Signadori Bio?
Yes. We list 6 companies like Signadori Bio, including Moderna, BioNTech and Kite Pharma.
Is Signadori Bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Signadori Bio is 63 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Signadori Bio raised?
Signadori Bio has raised a total of $12.2M in funding. The most recent round on record is Seed Extension.
SEC filings, insider activity, nonprofit links and pay benchmarks for Signadori Bio:
Company details: from public sources. Funding: 2 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Signadori Bio and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini


